one of the best announcement on ASX today RHT
Some facts About RHT: FDA approval this will bring below mentioned value to the company
1.8 to 2.3 billion people living with non alcoholic fatty liver disease (NAFLD)Each NAFLD test cost roughly around $100, but I take $50 to call it fair value
1% of that population =18million x 50 dollars per scan = $900 million revenue
10% of the population = 180mx $50 per scan = $9billion revenue
This valuation based on only 1 product, What should be real value if we consider all 6 products RHT has
As per their last announcement RHT working on other AI projects for approval . The company filed a provisional patent with IP Australia covering the application of novel Antisense Oligonucleotides (ASOs) to treat liver related disease. If successfully granted, the patent would have a term of 20 years from the complete (PCT) filing date (see ASX announcements dated 25 May 2020 and 26 May 2020).• A 510(k) application for regula clearance was submitted to the United States Food and Drug Administration (“US FDA”) for the Company’s newly developed AI solution, HepaFat-AI (see ASX announcement dated 6 April 2020).• The Company’s cash on hand as of 30 June 2020 was $6.97m, an increase of $115K over the March 2020 quarter.
- Forums
- ASX - By Stock
- RHT
- Ann: HepaFat-AI gains US FDA clearance
Ann: HepaFat-AI gains US FDA clearance, page-57
-
-
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHT (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.47M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 73500 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 45765 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 73500 | 0.056 |
1 | 79523 | 0.054 |
1 | 200000 | 0.053 |
1 | 96000 | 0.052 |
2 | 241999 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.059 | 45765 | 2 |
0.060 | 70000 | 1 |
0.065 | 55000 | 2 |
0.067 | 29344 | 1 |
0.069 | 45000 | 1 |
Last trade - 16.12pm 21/10/2024 (20 minute delay) ? |
Featured News
RHT (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online